Author

Yiqiao Lu

Women's Hospital, School of Medicine, Zhejiang University

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Bioinformatics· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:benchmarking· 1 Assay:bulk RNA-seq· 1 Research Focus:differential expression· 1 Organism:human· 1 Approach:machine learning (classical)· 1 Assay:scRNA-seq· 1 Approach:statistical model· 1

Frequent Co-Authors

Bin SuniD· 1 shared Chengze WangiD· 1 shared Wei Liu· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

3 top collaborators · 3 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperBioinformatics

Bin SunORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Systems Pharmacology Reveals Type I Interferon and Myeloid-Like B Cell Reprogramming as Druggable Axes in Antiphospholipid Syndrome

Bin Sun, Yiqiao Lu, Wei Liu, Chengze Wang

The paper identifies druggable targets in antiphospholipid syndrome using systems pharmacology, revealing two key modules linked to interferon-I signaling and degranulation pathways.

bioRxiv · Apr 30, 2026 · PreprintBioinformatics